Halozyme Therapeutics Inc (HALO)

Total asset turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	US$ in thousands	809,880	641,313	435,810	267,594	195,992
Total assets	US$ in thousands	1,733,270	1,841,510	1,104,430	579,924	565,874
Total asset turnover		0.47	0.35	0.39	0.46	0.35

December 31, 2023 calculation

Total asset turnover = Revenue ÷ Total assets
= $809,880K ÷ $1,733,270K
= 0.47

The total asset turnover ratio of Halozyme Therapeutics Inc. has shown fluctuations over the past five years. The ratio indicates how efficiently the company is utilizing its assets to generate revenue.

In 2023, the total asset turnover ratio increased to 0.48 from 0.36 in 2022, indicating an improvement in the company's ability to generate revenue in relation to its total assets. This could suggest better asset utilization or increased sales efficiency during the year.

However, the ratio was higher in 2020 at 0.46 compared to 2023, indicating that the company was more efficient in generating revenue from its assets in the past. Similarly, in 2019, the total asset turnover was at 0.35, lower than 2023, suggesting that the company's asset utilization was less efficient in that year.

Overall, the trend in the total asset turnover ratio for Halozyme Therapeutics Inc. has been mixed, with fluctuations observed over the five-year period. Investors and stakeholders may want to further investigate the underlying reasons for these fluctuations to assess the company's operational and financial performance.